5.95
price down icon1.49%   -0.09
after-market After Hours: 5.84 -0.11 -1.85%
loading
Neogen Corp stock is traded at $5.95, with a volume of 4.47M. It is down -1.49% in the last 24 hours and up +8.18% over the past month. Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
See More
Previous Close:
$6.04
Open:
$6.09
24h Volume:
4.47M
Relative Volume:
0.73
Market Cap:
$1.29B
Revenue:
$912.20M
Net Income/Loss:
$-23.53M
P/E Ratio:
-51.74
EPS:
-0.115
Net Cash Flow:
$-124.88M
1W Performance:
+5.68%
1M Performance:
+8.18%
6M Performance:
+6.63%
1Y Performance:
-58.77%
1-Day Range:
Value
$5.92
$6.21
1-Week Range:
Value
$5.55
$7.17
52-Week Range:
Value
$3.8701
$16.79

Neogen Corp Stock (NEOG) Company Profile

Name
Name
Neogen Corp
Name
Phone
(517) 372-9200
Name
Address
620 LESHER PLACE, LANSING
Name
Employee
1,456
Name
Twitter
@NeogenCorp
Name
Next Earnings Date
2025-10-09
Name
Latest SEC Filings
Name
NEOG's Discussions on Twitter

Compare NEOG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
NEOG
Neogen Corp
5.95 1.31B 912.20M -23.53M -124.88M -0.115
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
524.58 198.17B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
205.14 144.97B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
633.32 49.29B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
138.23 38.73B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
203.77 33.69B 15.70B 1.24B 2.01B 6.9036

Neogen Corp Stock (NEOG) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-29-25 Downgrade William Blair Outperform → Mkt Perform
Dec-19-24 Initiated Guggenheim Buy
Jun-16-23 Initiated Wells Fargo Overweight
Nov-22-22 Upgrade William Blair Mkt Perform → Outperform
Jul-12-22 Initiated Piper Sandler Neutral
May-23-19 Initiated Guggenheim Neutral
Dec-05-17 Resumed ROTH Capital Neutral
Jul-14-17 Initiated CL King Neutral
Jun-05-14 Initiated William Blair Mkt Perform
Mar-31-11 Upgrade Hilliard Lyons Underperform → Neutral
Sep-25-09 Reiterated Roth Capital Buy
Jul-22-09 Reiterated Roth Capital Buy
Mar-20-09 Reiterated Roth Capital Buy
Jan-07-09 Reiterated Roth Capital Buy
Sep-25-08 Reiterated Roth Capital Buy
Jan-04-08 Reiterated Roth Capital Buy
Sep-28-07 Reiterated Roth Capital Buy
Jul-25-07 Reiterated Roth Capital Buy
Jul-09-07 Reiterated Roth Capital Buy
May-08-07 Initiated Susquehanna Financial Positive
View All

Neogen Corp Stock (NEOG) Latest News

pulisher
10:33 AM

Neogen : Transcript (2025 10 09 transcript fy26q1 earnings) - MarketScreener

10:33 AM
pulisher
09:21 AM

Technical analysis overview for Neogen Corporation stock2025 Winners & Losers & Safe Entry Momentum Tips - newser.com

09:21 AM
pulisher
08:50 AM

Price momentum metrics for Neogen Corporation explainedTrade Exit Summary & Weekly High Potential Alerts - newser.com

08:50 AM
pulisher
03:18 AM

Inspire Investing LLC Acquires 46,753 Shares of Neogen Corporation $NEOG - MarketBeat

03:18 AM
pulisher
Oct 12, 2025

Neogen Corp. Stock Hits Day Low of $5.57 Amid Price Pressure - Markets Mojo

Oct 12, 2025
pulisher
Oct 10, 2025

Neogen (NASDAQ:NEOG) Releases Earnings Results, Beats Expectations By $0.12 EPS - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Neogen (NASDAQ:NEOG) Shares Gap UpWhat's Next? - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Neogen (NEOG): Losses Deepen 90.4% Annually, Market Discounts Turnaround Narrative - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Stock Traders Buy Large Volume of Call Options on Neogen (NASDAQ:NEOG) - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Neogen's (NEOG) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

NEOG Q3 Deep Dive: Q3 Results, Guidance Reaffirmed, and Operational Turnaround in Focus - The Globe and Mail

Oct 10, 2025
pulisher
Oct 10, 2025

Decoding Neogen Corp (NEOG): A Strategic SWOT Insight - GuruFocus

Oct 10, 2025
pulisher
Oct 09, 2025

Neogen: Fiscal Q1 Earnings Snapshot - Connecticut Post

Oct 09, 2025
pulisher
Oct 09, 2025

Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Animal Tester Neogen Sticks To Annual Forecast Despite Tariffs - Benzinga

Oct 09, 2025
pulisher
Oct 09, 2025

Why Neogen (NEOG) Stock Is Trading Up Today - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen Corp reports results for the quarter ended August 31Earnings Summary - TradingView

Oct 09, 2025
pulisher
Oct 09, 2025

Earnings call transcript: Neogen beats Q1 2026 earnings expectations - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen Outpaces Estimates But Faces Lower Sales After Divestiture - Finimize

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen Q1 Adj. EPS Meets Estimates; Reaffirms FY26 Revenue Outlook; Stock Up 8.6% - Nasdaq

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen (NEOG) Q1 Earnings Lag Estimates - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen Q1 FY26 slides: revenue dips but company maintains full-year outlook - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen Corp (NEOG) Reports Q1 EPS of $0.17, Beating Estimates; R - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen (NASDAQ:NEOG) Exceeds Q3 Expectations, Stock Soars - Yahoo Finance

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen shares soar 12% as first quarter results top expectations By Investing.com - Investing.com Canada

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen shares soar 12% as first quarter results top expectations - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen earnings beat by $0.11, revenue topped estimates - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen Corporation Q1 2026 Financial Results - TradingView

Oct 09, 2025
pulisher
Oct 09, 2025

Neogen Announces First-Quarter 2026 Results - Yahoo Finance

Oct 09, 2025
pulisher
Oct 07, 2025

Neogen (NEOG) Q3 Earnings Report Preview: What To Look For - Barchart.com

Oct 07, 2025
pulisher
Oct 07, 2025

Could Neogen's (NEOG) Renewed Equestrian Partnership Reveal More About Its Animal Health Strategy? - Yahoo Finance

Oct 07, 2025
pulisher
Oct 07, 2025

Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings - Benzinga

Oct 07, 2025
pulisher
Oct 06, 2025

Neogen (NASDAQ:NEOG) Stock Price Down 6.4%Should You Sell? - MarketBeat

Oct 06, 2025
pulisher
Oct 06, 2025

Can Neogen’s (NEOG) Renewed Equestrian Partnership Strengthen Its Position in Animal Health Solutions? - simplywall.st

Oct 06, 2025
pulisher
Oct 06, 2025

Wall Street's Insights Into Key Metrics Ahead of Neogen (NEOG) Q1 Earnings - Yahoo Finance

Oct 06, 2025
pulisher
Oct 04, 2025

Assessing Neogen (NEOG) Valuation After Recent Share Price Uptick - simplywall.st

Oct 04, 2025
pulisher
Oct 02, 2025

Analysts Estimate Neogen (NEOG) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance

Oct 02, 2025
pulisher
Oct 02, 2025

Neogen (NEOG) to Release Earnings on Thursday - MarketBeat

Oct 02, 2025
pulisher
Oct 01, 2025

Neogen (NASDAQ:NEOG) Coverage Initiated at CJS Securities - MarketBeat

Oct 01, 2025
pulisher
Oct 01, 2025

Neogen (NEOG): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance

Oct 01, 2025
pulisher
Sep 30, 2025

Neogen (NEOG) Stock Trades Up, Here Is Why - Yahoo Finance

Sep 30, 2025
pulisher
Sep 30, 2025

Will Neogen Corporation stock reach Wall Street targetsQuarterly Risk Review & Daily Risk Controlled Trade Plans - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Earnings visualization tools for Neogen CorporationOil Prices & Detailed Earnings Play Strategies - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Neogen Corporation (NASDAQ:NEOG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Sep 29, 2025
pulisher
Sep 29, 2025

NEOG: CJS Securities Initiates Coverage with 'Market Perform' Ra - GuruFocus

Sep 29, 2025
pulisher
Sep 27, 2025

What analysts say about Neogen Corporation NG2 stockTechnical Analysis Insights & Ride the Wave of Market-Beating Growth - earlytimes.in

Sep 27, 2025
pulisher
Sep 26, 2025

Banque Pictet & Cie SA Has $9.01 Million Position in Neogen Corporation $NEOG - MarketBeat

Sep 26, 2025
pulisher
Sep 25, 2025

Neogen extends partnership with US Equestrian Federation - Investing.com

Sep 25, 2025
pulisher
Sep 25, 2025

Leading Animal Health Company Neogen Strengthens US Equestrian Partnership for Critical Horse Safety Programs - Stock Titan

Sep 25, 2025

Neogen Corp Stock (NEOG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Neogen Corp Stock (NEOG) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Jones Douglas Edward
Former COO
Oct 07 '25
Option Exercise
5.63
12,940
72,852
94,787
ADENT JOHN EDWARD
Former CEO
Oct 07 '25
Option Exercise
5.63
32,936
185,430
339,948
Woteki Catherine E
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
15,315
Tobin James P
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
39,545
RODRIGUEZ RAFAEL A
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
17,019
Gupta Aashima
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
23,988
Green Ronald D
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
14,852
CAPELLO JEFFREY D
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
28,700
BOREL JAMES C
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
92,545
BOEHM WILLIAM T
Director
Oct 07 '25
Option Exercise
5.63
2,071
11,660
38,285
diagnostics_research WAT
$336.33
price up icon 1.61%
diagnostics_research DGX
$182.78
price down icon 0.70%
diagnostics_research LH
$276.64
price down icon 0.45%
$174.17
price up icon 2.89%
diagnostics_research MTD
$1,284.74
price up icon 0.87%
diagnostics_research IQV
$203.77
price up icon 2.83%
Cap:     |  Volume (24h):